EKF Diagnostics (LON:EKF) Stock Crosses Above 200-Day Moving Average – Here’s What Happened

EKF Diagnostics Holdings plc (LON:EKF) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 25.37 and traded as high as GBX 25.41. EKF Diagnostics shares last traded at GBX 24.50, with a volume of 126,978 shares trading hands.

Analyst Ratings Changes

Separately, Stifel Nicolaus restated a “buy” rating and set a GBX 35 target price on shares of EKF Diagnostics in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of GBX 35.

EKF Diagnostics Price Performance

The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16. The firm has a market cap of £107.63 million, a price-to-earnings ratio of 53.19 and a beta of 0.53. The company’s fifty day moving average is GBX 25.54 and its two-hundred day moving average is GBX 25.37.

EKF Diagnostics (LON:EKF) last issued its quarterly earnings data on Tuesday, March 24th. The company reported GBX 0.47 EPS for the quarter. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%. Equities research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.